Opportunistic infections in patients with haematological malignancies in Nigeria

Opportunistic infections in patients with haematological malignancies in Nigeria

Haematological malignancies (HM) are common clinical conditions encountered in Nigeria. Patients with haematological cancers are immunocompromised and as such are at risk of invasive fungal infections (IFIs). The objective of this review was to highlight the paucity of data on IFIs in patients with...

Full description

Bibliographic Details
Main Authors:	Bassey Ewa Ekeng, Kingsley Akaba, Christian Ide, Rita Oladele
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2022-01-01
Series:	Journal of Clinical and Scientific Research
Subjects:	cancers fungal haematological infections malignancies
Online Access:	http://www.jcsr.co.in/article.asp?issn=2277-5706;year=2022;volume=11;issue=3;spage=175;epage=180;aulast=Ekeng

Similar Items

Biosimilars for Haematologic Malignancies: The Path to Sustainable Care
by: Paul Cornes, et al.
Published: (2017-08-01)

EARLY AND LATE COMPLICATIONS RELATED TO CENTRAL VENOUS CATHETERS IN HAEMATOLOGICAL MALIGNANCIES: A RETROSPECTIVE ANALYSIS OF 1102 PATIENTS
by: Salvatore Giacomo Morano, et al.
Published: (2014-02-01)

Haematological nurses' experiences about palliative care trajectories of patients with life‐threatening haematological malignancies: A qualitative study
by: Siobhan McPherson, et al.
Published: (2023-05-01)

Effectiveness and safety of isavuconazole prophylaxis for invasive fungal infections in the haematologic setting
by: Yang Ping, et al.
Published: (2022-12-01)

Outcomes of Antifungal Prophylaxis in High-Risk Haematological Patients (AML under Intensive Chemotherapy): The SAPHIR Prospective Multicentre Study
by: Jean-Pierre Gangneux, et al.
Published: (2020-11-01)

In Vitro 3D Models of Haematological Malignancies: Current Trends and the Road Ahead?
by: Carlotta Mattioda, et al.
Published: (2025-01-01)

Opportunistic Fungal Infections in Haematologic Diseases and Bone Marrow Transplantation (BMT) Recipients.
by: Seyyed Amir Ghiasian, et al.
Published: (1996-09-01)

Fusariosis in haematological malignancy – the skin is the clue… Experiences from the National Cancer Institute of Sri Lanka: a case report
by: M. N. Jayawardena, et al.
Published: (2021-04-01)

Bendamustine treatment of haematological malignancies: significant risks of opportunistic viral, fungal and bacterial infections
by: Tony K.Y. Wu, et al.
Published: (2022-12-01)

One Omics Approach Does Not Rule Them All: The Metabolome and the Epigenome Join Forces in Haematological Malignancies
by: Antonia Kalushkova, et al.
Published: (2021-10-01)

Editorial: New immunotherapeutic and pharmacological targets and strategies in haematological malignancies
by: Mark Thomas Shaw Williams, et al.
Published: (2023-02-01)

Changes in respiratory infection trends during the COVID-19 pandemic in patients with haematologic malignancy
by: Jiwon Ryoo, et al.
Published: (2024-05-01)

Targeting hypoxia in solid and haematological malignancies
by: Bill Harris, et al.
Published: (2022-11-01)

Clinical and laboratory characteristics of patients with symptomatic secondary immunodeficiency following the treatment of haematological malignancies
by: Adrian M. Shields, et al.
Published: (2023-05-01)

Eosinophilic dermatosis of haematologic malignancy treated with ibrutinib: A case report
by: Giulia Greta Dradi, et al.
Published: (2025-03-01)

Efficacy of a culturally tailored cognitive-behavioural intervention for Ethiopian children with haematological malignancies: study protocol for randomised controlled trial
by: Tenaw Gualu Melesse, et al.
Published: (2022-09-01)

Non‐m6A RNA modifications in haematological malignancies
by: Meiling Chen, et al.
Published: (2024-06-01)

Immunotherapy and immunomodulation for haematological malignancies
by: Mussai, F, et al.
Published: (2012)

Maternal autoimmune disease and offspring risk of haematological malignancies: a case–control studyResearch in context
by: Shu-Ning Liu, et al.
Published: (2024-09-01)

Severe bleeding events among critically ill patients with haematological malignancies
by: Clara Vigneron, et al.
Published: (2024-10-01)

Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022Research in context
by: Jon Salmanton-García, et al.
Published: (2024-05-01)

Patterns of haematological malignancies on bone marrow examination: A 3-year institutional experience
by: Harish Chandra, et al.
Published: (2022-01-01)

Chinese parents’ caregiving ability for children with haematological malignancies: A latent class analysis
by: Jingting Wang, et al.
Published: (2022-07-01)

KINETICS AND ROLE OF PANCREATIC STONE PROTEIN AND MIDREGIONAL PROADRENOMEDULLIN AS PREDICTORS OF SEPSIS AND BACTEREMIA IN CHILDREN WITH HAEMATOLOGICAL MALIGNANCIES.
by: Vasiliki Antari, et al.
Published: (2023-10-01)

The Feasibility of Ibrexafungerp for the Treatment of Fungal Infections in Patients with Hematological Malignancies
by: Justinas Daraskevicius, et al.
Published: (2022-04-01)

Eosinophilic dermatosis of haematological malignancy (EDHM): A series of nine cases
by: Farrah Bakr, et al.
Published: (2022-12-01)

A critical assessment of dose effects of post‐thaw CD34 on autologous stem cell transplantation treatment of haematological malignancies
by: Gustavo de Carvalho Duarte, et al.
Published: (2023-05-01)

Certainty in uncertainty: Determining the rate and reasons for reclassification of variants of uncertain significance in haematological malignancies
by: Anoop K. Enjeti, et al.
Published: (2024-10-01)

Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registryResearch in context
by: Jon Salmanton-García, et al.
Published: (2023-04-01)

A population-based analysis of invasive fungal disease in haematology-oncology patients using data linkage of state-wide registries and administrative databases: 2005 - 2016
by: Jake C. Valentine, et al.
Published: (2019-03-01)

Outcomes of patients with haematological malignancies and febrile neutropenia at the Universitas Academic Hospital multidisciplinary intensive care unit, Free State Province, South Africa
by: C D S Martins, et al.
Published: (2023-04-01)

COVID-19 in patients with haematologic malignancies: Effect of RNAemia on clinical outcome in vaccinated patients
by: Javier Martín-Escolano, et al.
Published: (2024-09-01)

A Randomized Placebo- Controlled Double Blind Clinical Trial of Quercetin in the Prevention and Treatment of Chemotherapy-Induced Oral Mucositis
by: Mohammad Mahdi Kooshyar, et al.
Published: (2017-03-01)

Pulmonary and Extrapulmonary Manifestations of Fungal Infections Misdiagnosed as Tuberculosis: The Need for Prompt Diagnosis and Management
by: Bassey E. Ekeng, et al.
Published: (2022-04-01)

Antimicrobial utilization and antimicrobial resistance in patients with haematological malignancies in Japan: a multi-centre cross-sectional study
by: Wataru Mimura, et al.
Published: (2020-02-01)

The first suspected disseminated Hormographiella aspergillata infection in China, diagnosed using metagenomic next-generation sequencing: a case report and literature review
by: Qian Wang, et al.
Published: (2023-12-01)

The mediating effect of stigma on the relationship between fear of disease progression and social alienation in patients with haematological malignancies
by: Dan Shi, et al.
Published: (2024-12-01)

Telemedicine system for the diagnosis and management of invasive fungal infections in Nigeria
by: Solomon Nwaneri, et al.
Published: (2023-01-01)

Effects of Malaria Infection on Haematological Parameters among Patients in Kano State, Nigeria
by: Adamu, A. Y., et al.
Published: (2018-12-01)

Infections Mimicking Malignancy in Kano, Nigeria: A Teaching Hospital Experience
by: Abdulrazaq Jimoh Ajanaku, et al.
Published: (2022-04-01)